ncRNA
CASC2
Specific or universal ncRNAs
Universal ncRNAs
Class
Long non-coding RNA
Biomarker
No
Biomarker application
Upstream regulatory factor
Not available
Downstream target
miR-21
Differential expression in
recurrence vs. nonrecurrence
Up
Cancer name
Oral Squamous Cell Carcinoma
Alias
Mouth Cancer
Cancer site
Lip, Oral Cavity
Recurrence type
Local Recurrence
Overall survival rate of patients with
high ncRNA expression
Down
ncRNA differential expression in
cancer
patients vs. health people
Down
Number of patients
122
Male patients
70
Female patients
52
Age range and number
64(<50)+58(>50)
Recurrence patients
Not available
Recurrence patients male:female
Not available
Recurrence patients age range
Not available
Recurrence mean age
Not available
Sites of recurrence
Not available
Patients without recurrence
Not available
Patients without recurrence male:female
Patients without recurrence age range
Not available
Patients without recurrence mean age
Not available
PMID
Description
Plasma levels of CASC2 were significantly increased in patients with local recurrence than in patients without recurrence.
Tissue resource
human oral squamous cell carcinoma cell lines SCC25
human oral squamous cell carcinoma cell lines SCC090
oral squamous cell carcinoma tumor tissues and adjacent healthy tissues
Experiment
qRT-PCR
Institute
American Type Culture Collection
the Ningbo No.2 Hospital
Country
USA
China
Continent
North American
Asia